Stay updated on Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T05:12:40.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has been updated to include the term 'Metastatic Breast Cancer' and a new EudraCT number, while significant details regarding the study's design, inclusion and exclusion criteria have been removed.
    Difference
    14%
    Check dated 2025-04-16T14:40:23.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 17, 2025. However, the deletion of the date March 25, 2025, does not significantly impact the core content.
    Difference
    0.3%
    Check dated 2025-04-09T09:49:10.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version release, moving from v2.14.2 to v2.14.3, and the last update date has changed from February 17, 2025, to March 25, 2025.
    Difference
    0.2%
    Check dated 2025-04-01T23:32:49.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new study on Trastuzumab Emtansine in combination with Atezolizumab, with significant changes in the number of study locations and the estimated last update date. The study now includes 50 locations compared to the previous 108, and the last update is now estimated for February 2025.
    Difference
    29%
    Check dated 2025-02-24T20:58:38.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    1.0%
    Check dated 2025-02-10T09:53:27.000Z thumbnail image

Stay in the know with updates to Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page.